Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML

Smith, S. M., Zhang, S., Sundaram, V., Roth, M., Andolina, J. R., Schapira, L., Sakamoto, K. M., Kolb, E. A., Hijiya, N., & Chaudhury, S. (2021). Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML. Pediatric Hematology and Oncology, 39(5), 453–467. https://doi.org/10.1080/08880018.2021.2017085

Authors:

Stephanie M Smith

Shiqi Zhang

Vandana Sundaram

Michael Roth

Jeffrey R Andolina

Lidia Schapira

Kathleen M Sakamoto

E Anders Kolb

Nobuko Hijiya

Sonali Chaudhury

Affiliated Authors: